» Articles » PMID: 34298093

Iron Deficiency Exacerbates Cisplatin- or Rhabdomyolysis-induced Acute Kidney Injury Through Promoting Iron-catalyzed Oxidative Damage

Overview
Date 2021 Jul 23
PMID 34298093
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Iron deficiency is the most common micronutrient deficiency worldwide. While iron deficiency is known to suppress embryonic organogenesis, its effect on the adult organ in the context of clinically relevant damage has not been considered. Here we report that iron deficiency is a risk factor for nephrotoxic intrinsic acute kidney injury of the nephron (iAKI). Iron deficiency exacerbated cisplatin-induced iAKI by markedly increasing non-heme catalytic iron and Nox4 protein which together catalyze production of hydroxyl radicals followed by protein and DNA oxidation, apoptosis and ferroptosis. Crosstalk between non-heme catalytic iron/Nox4 and downstream oxidative damage generated a mutual amplification cycle that facilitated rapid progression of cisplatin-induced iAKI. Iron deficiency also exacerbated a second model of iAKI, rhabdomyolysis, via increasing catalytic heme-iron. Heme-iron induced lipid peroxidation and DNA oxidation by interacting with Nox4-independent mechanisms, promoting p53/p21 activity and cellular senescence. Our data suggests that correcting iron deficiency and/or targeting specific catalytic iron species are strategies to mitigate iAKI in a wide range of patients with diverse forms of kidney injury.

Citing Articles

Deciphering ferroptosis in critical care: mechanisms, consequences, and therapeutic opportunities.

Tan R, Ge C, Yan Y, Guo H, Han X, Zhu Q Front Immunol. 2024; 15:1511015.

PMID: 39737174 PMC: 11682965. DOI: 10.3389/fimmu.2024.1511015.


The significance of ferroptosis in renal diseases and its therapeutic potential.

Jiang M, Wu S, Xie K, Zhou G, Zhou W, Bao P Heliyon. 2024; 10(16):e35882.

PMID: 39220983 PMC: 11363859. DOI: 10.1016/j.heliyon.2024.e35882.


The role of ferroptosis in acute kidney injury: mechanisms and potential therapeutic targets.

Yu Y, Zhang L, Zhang D, Dai Q, Hou M, Chen M Mol Cell Biochem. 2024; 480(2):759-784.

PMID: 38943027 DOI: 10.1007/s11010-024-05056-3.


Hazel Leaf Polyphenol Extract Alleviated Cisplatin-Induced Acute Kidney Injury by Reducing Ferroptosis through Inhibiting Hippo Signaling.

Sun M, Chang H, Jiang F, Zhang W, Yang Q, Wang X Molecules. 2024; 29(8).

PMID: 38675549 PMC: 11051766. DOI: 10.3390/molecules29081729.


Molecular Mechanisms of Ferroptosis and Their Involvement in Acute Kidney Injury.

Liu J, Han X, Zhou J, Leng Y J Inflamm Res. 2023; 16:4941-4951.

PMID: 37936596 PMC: 10627075. DOI: 10.2147/JIR.S427505.


References
1.
Guerrero-Hue M, Garcia-Caballero C, Palomino-Antolin A, Rubio-Navarro A, Vazquez-Carballo C, Herencia C . Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J. 2019; 33(8):8961-8975. DOI: 10.1096/fj.201900077R. View

2.
Yin H, Xu L, Porter N . Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011; 111(10):5944-72. DOI: 10.1021/cr200084z. View

3.
Sharma S, Leaf D . Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention. J Am Soc Nephrol. 2019; 30(11):2060-2071. PMC: 6830795. DOI: 10.1681/ASN.2019060595. View

4.
Shah S, Rajapurkar M, Baliga R . The role of catalytic iron in acute kidney injury. Clin J Am Soc Nephrol. 2011; 6(10):2329-31. DOI: 10.2215/CJN.08340811. View

5.
Netz D, Stith C, Stumpfig M, Kopf G, Vogel D, Genau H . Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes. Nat Chem Biol. 2011; 8(1):125-32. PMC: 3241888. DOI: 10.1038/nchembio.721. View